Next Article in Journal
The Infectious Disease Burden Among War Related Internally Displaced People in the Lviv Region of Ukraine
Previous Article in Journal
Synthesizing and Assessing Influenza Vaccine Evidence: Strengths and Limitations of the Recent ECDC Report on the Effectiveness of New and Enhanced Influenza Vaccines. Communication on: The “European Centre for Disease Prevention and Control. Systematic Review Update on the Efficacy, Effectiveness and Safety of Newer and Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory Confirmed Influenza in Individuals Aged 18 Years and Over. Stockholm: ECDC; 2024”
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
GERMS
Volume 14
Issue 4
10.18683/germs.2024.1442
germs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH)

by
Oana Săndulescu
1,2,3,*,
İmran Hasanoğlu
3,4,
Mojca Matičič
3,5 and
on behalf of ESGVH
1
Department of Infectious Diseases I, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, and National Institute for Infectious Diseases "Prof. Dr. Matei Balș", No. 1 Dr. Calistrat Grozovici street, 021105 Bucharest, Romania
2
Academy of Romanian Scientists, Bucharest, Romania
3
Executive Committee of the ESCMID Study Group for Viral Hepatitis (ESGVH), Basel, Switzerland
4
Department of Infectious Disease and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Üniversiteler, 1604. Cd No:9, 06800 Çankaya, Ankara, Turkey
5
Faculty of Medicine, University of Ljubljana, and Clinic for Infectious Diseases, University Medical Centre Ljubljana, Vrazov trg 1, 1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
GERMS 2024, 14(4), 320-321; https://doi.org/10.18683/germs.2024.1442
Submission received: 30 September 2024 / Revised: 31 October 2024 / Accepted: 30 November 2024 / Published: 31 December 2024
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In 2024, the global fight against viral hepatitis has made steady strides, marking yet another important year in the effort to eliminate this significant public health challenge.[...]

Share and Cite

MDPI and ACS Style

Săndulescu, O.; Hasanoğlu, İ.; Matičič, M.; on behalf of ESGVH. Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS 2024, 14, 320-321. https://doi.org/10.18683/germs.2024.1442

AMA Style

Săndulescu O, Hasanoğlu İ, Matičič M, on behalf of ESGVH. Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS. 2024; 14(4):320-321. https://doi.org/10.18683/germs.2024.1442

Chicago/Turabian Style

Săndulescu, Oana, İmran Hasanoğlu, Mojca Matičič, and on behalf of ESGVH. 2024. "Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH)" GERMS 14, no. 4: 320-321. https://doi.org/10.18683/germs.2024.1442

APA Style

Săndulescu, O., Hasanoğlu, İ., Matičič, M., & on behalf of ESGVH. (2024). Updates in Viral Hepatitis in 2024—Summary of Education, Research and Leadership Activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). GERMS, 14(4), 320-321. https://doi.org/10.18683/germs.2024.1442

Article Metrics

Back to TopTop